Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells
To develop an effective antitumor immunotherapy for B-lineage non-Hodgkin's lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B-cell marker) and CD3 (T-cell antigen). Here, we report the effective killing of malignant primary B cells from patients with...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 June 2004
|
| In: |
International journal of cancer
Year: 2004, Volume: 112, Issue: 3, Pages: 509-518 |
| ISSN: | 1097-0215 |
| DOI: | 10.1002/ijc.20417 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.20417 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20417 
|
| Author Notes: | Uwe Reusch, Fabrice Le Gall, Manfred Hensel, Gerhard Moldenhauer, Anthony D. Ho, Melvyn Little and Sergey M. Kipriyanov |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1780200269 | ||
| 003 | DE-627 | ||
| 005 | 20220820085558.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211203s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ijc.20417 |2 doi | |
| 035 | |a (DE-627)1780200269 | ||
| 035 | |a (DE-599)KXP1780200269 | ||
| 035 | |a (OCoLC)1341430876 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Reusch, Uwe |d 1967- |e VerfasserIn |0 (DE-588)123432405 |0 (DE-627)706297385 |0 (DE-576)293706778 |4 aut | |
| 245 | 1 | 0 | |a Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells |c Uwe Reusch, Fabrice Le Gall, Manfred Hensel, Gerhard Moldenhauer, Anthony D. Ho, Melvyn Little and Sergey M. Kipriyanov |
| 264 | 1 | |c 16 June 2004 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 03.12.2021 | ||
| 520 | |a To develop an effective antitumor immunotherapy for B-lineage non-Hodgkin's lymphoma, we constructed a tetravalent tandem diabody (tanDb) specific for both human CD19 (B-cell marker) and CD3 (T-cell antigen). Here, we report the effective killing of malignant primary B cells from patients with B-cell chronic lymphocytic leukemia (B-CLL) by autologous T cells induced by tanDb at very low E:T ratios. Mononuclear cells from patients with B-CLL were cultured with bispecific antibody fragments in either the presence or absence of monospecific anti-CD28 antibody. Use of tetravalent tanDbs caused almost quantitative elimination of malignant B cells from the blood samples of 19 patients and some cytotoxic activity in 3 of 23 analyzed cases. In contrast, the structurally similar but bivalent diabody and single-chain diabody demonstrated nearly no antitumor activity in an autologous system. tanDb-induced activation and proliferation of T cells occurred only in the presence of CD19+ target cells. Expression of the B7-1 (CD80) and B7-2 (CD86) molecules on the surface of leukemia cells made unnecessary the additional CD28-costimulation of T cells. When only a few tanDb molecules were present, the effect of CD28 costimulation on T-cell activation was more pronounced. Depending on the patient sample, we observed a 10- to 1,000-fold decrease of the half-maximal concentrations of tanDb for cell lysis. Upon CD28 crosslinking by agonistic MAb, specific tumor cell lysis was found at tanDb concentrations as low as 0.5 pM. These data demonstrate that the tetravalent CD19×CD3 tanDb might be a promising tool for the immunotherapy of human B-cell leukemias and lymphomas. © 2004 Wiley-Liss, Inc. | ||
| 650 | 4 | |a B-cell chronic lymphocytic leukemia | |
| 650 | 4 | |a CD19 | |
| 650 | 4 | |a CD3 | |
| 650 | 4 | |a immunotherapy | |
| 650 | 4 | |a tandem diabody | |
| 700 | 1 | |a Le Gall, Fabrice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hensel, Manfred |d 1964- |e VerfasserIn |0 (DE-588)1065849729 |0 (DE-627)816878307 |0 (DE-576)425541908 |4 aut | |
| 700 | 1 | |a Moldenhauer, Gerhard |e VerfasserIn |0 (DE-588)1054128634 |0 (DE-627)791055701 |0 (DE-576)410008443 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Little, Melvyn |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kipriyanov, Sergey M. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of cancer |d Bognor Regis : Wiley-Liss, 1966 |g 112(2004), 3, Seite 509-518 |h Online-Ressource |w (DE-627)269532781 |w (DE-600)1474822-8 |w (DE-576)079876129 |x 1097-0215 |7 nnas |a Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells |
| 773 | 1 | 8 | |g volume:112 |g year:2004 |g number:3 |g pages:509-518 |g extent:10 |a Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells |
| 856 | 4 | 0 | |u https://doi.org/10.1002/ijc.20417 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.20417 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211203 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1054128634 |a Moldenhauer, Gerhard |m 1054128634:Moldenhauer, Gerhard |d 50000 |e 50000PM1054128634 |k 0/50000/ |p 4 | ||
| 998 | |g 1065849729 |a Hensel, Manfred |m 1065849729:Hensel, Manfred |d 910000 |d 910100 |e 910000PH1065849729 |e 910100PH1065849729 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 999 | |a KXP-PPN1780200269 |e 401348773X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 03.12.2021"],"relHost":[{"corporate":[{"role":"isb","display":"International Union against Cancer"}],"titleTranslated":[{"translated":"Journal international du cancer"}],"origin":[{"publisherPlace":"Bognor Regis","dateIssuedKey":"1966","dateIssuedDisp":"1966-","publisher":"Wiley-Liss"}],"title":[{"title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer"}],"part":{"extent":"10","issue":"3","text":"112(2004), 3, Seite 509-518","volume":"112","year":"2004","pages":"509-518"},"id":{"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"],"issn":["1097-0215"],"eki":["269532781"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"disp":"Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cellsInternational journal of cancer","recId":"269532781","titleAlt":[{"title":"Predictive oncology"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1966 -"]}],"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"id":{"doi":["10.1002/ijc.20417"],"eki":["1780200269"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells","title_sort":"Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells"}],"language":["eng"],"person":[{"role":"aut","display":"Reusch, Uwe","given":"Uwe","family":"Reusch"},{"family":"Le Gall","given":"Fabrice","display":"Le Gall, Fabrice","role":"aut"},{"role":"aut","family":"Hensel","given":"Manfred","display":"Hensel, Manfred"},{"display":"Moldenhauer, Gerhard","given":"Gerhard","family":"Moldenhauer","role":"aut"},{"family":"Ho","given":"Anthony Dick","display":"Ho, Anthony Dick","role":"aut"},{"given":"Melvyn","display":"Little, Melvyn","family":"Little","role":"aut"},{"family":"Kipriyanov","given":"Sergey M.","display":"Kipriyanov, Sergey M.","role":"aut"}],"origin":[{"dateIssuedDisp":"16 June 2004","dateIssuedKey":"2004"}],"name":{"displayForm":["Uwe Reusch, Fabrice Le Gall, Manfred Hensel, Gerhard Moldenhauer, Anthony D. Ho, Melvyn Little and Sergey M. Kipriyanov"]},"recId":"1780200269"} | ||
| SRT | |a REUSCHUWELEFFECTOFTE1620 | ||